|
Volumn 361, Issue 9371, 2003, Pages 1825-
|
Interferons in relapsing remitting multiple sclerosis.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
BETA1A INTERFERON;
GLATIRAMER;
PEPTIDE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
METHODOLOGY;
MULTIPLE SCLEROSIS;
NOTE;
PATIENT COMPLIANCE;
PATIENT SATISFACTION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
PATIENT COMPLIANCE;
PATIENT SATISFACTION;
PEPTIDES;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
EID: 0344950537
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)13423-X Document Type: Note |
Times cited : (5)
|
References (0)
|